Summary

The global Viral Vector CDMO Services market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Viral Vector CDMO Services refers to contract development and manufacturing organizations (CDMOs) that provide custom production and development services for viral vectors. Viral vectors are a commonly used gene therapy tool that deliver target genes into human cells to treat disease. Viral Vector CDMO Services provides various types of viral vector production services, including adenovirus vectors, AAV vectors, and LV vectors.
CDMO companies usually provide a full range of viral vector production and development services from the research stage to commercial production, including quality control, preparation, analysis, packaging and storage services. These services help accelerate the development and commercialization of gene therapy drugs and advance the field of gene therapy.
CDMO companies can also help customers develop production plans that suit their product needs, and provide customized technical support and solutions based on customer needs. Customers can choose the appropriate CDMO company as a partner based on their needs to ensure the high-quality production and successful launch of their gene therapy products.
United States market for Viral Vector CDMO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Viral Vector CDMO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Viral Vector CDMO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Viral Vector CDMO Services players cover Thermo Fisher Scientific, Lonza, Catalent, Charles River, Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Viral Vector CDMO Services Industry Forecast” looks at past sales and reviews total world Viral Vector CDMO Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Viral Vector CDMO Services sales for 2025 through 2031. With Viral Vector CDMO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Viral Vector CDMO Services industry.
This Insight Report provides a comprehensive analysis of the global Viral Vector CDMO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Viral Vector CDMO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Viral Vector CDMO Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Viral Vector CDMO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Viral Vector CDMO Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Viral Vector CDMO Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
AAV
Lentivirus
Adenovirus
HSV
Others
Segmentation by Application:
Vaccine Development
Gene Therapy
Academic Scientific Research Institution
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Lonza
Catalent
Charles River
Merck
SK pharmteco
Oxford Biomedica
AGC Biologics（MolMed）
Gene Universal
Polyplus (Sartorius)
CCRM
FUJIFILM Diosynth Biotechnologies
Biovian
Miltenyi Bioindustry
Aldevron
Takara Bio
Yposkesi
Genezen
GenScript ProBio
EurekaBio
Obio Technology
GeneSail Biotech
VectorBuilder
WuXi ATU
Ubrigene
Porton Biologics
Pharmaron
PackGene Biotechnology
Hillgene
Asymchem
Exthera
Flash Therapeutics
VIVEBiotech
FinVector
uBriGene
Eurogentec
VGXI

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Viral Vector CDMO Services Market Size (2020-2031)
2.1.2 Viral Vector CDMO Services Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Viral Vector CDMO Services by Country/Region (2020, 2024 & 2031)
2.2 Viral Vector CDMO Services Segment by Type
2.2.1 AAV
2.2.2 Lentivirus
2.2.3 Adenovirus
2.2.4 HSV
2.2.5 Others
2.3 Viral Vector CDMO Services Market Size by Type
2.3.1 Viral Vector CDMO Services Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Viral Vector CDMO Services Market Size Market Share by Type (2020-2025)
2.4 Viral Vector CDMO Services Segment by Application
2.4.1 Vaccine Development
2.4.2 Gene Therapy
2.4.3 Academic Scientific Research Institution
2.4.4 Others
2.5 Viral Vector CDMO Services Market Size by Application
2.5.1 Viral Vector CDMO Services Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Viral Vector CDMO Services Market Size Market Share by Application (2020-2025)
3 Viral Vector CDMO Services Market Size by Player
3.1 Viral Vector CDMO Services Market Size Market Share by Player
3.1.1 Global Viral Vector CDMO Services Revenue by Player (2020-2025)
3.1.2 Global Viral Vector CDMO Services Revenue Market Share by Player (2020-2025)
3.2 Global Viral Vector CDMO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Viral Vector CDMO Services by Region
4.1 Viral Vector CDMO Services Market Size by Region (2020-2025)
4.2 Global Viral Vector CDMO Services Annual Revenue by Country/Region (2020-2025)
4.3 Americas Viral Vector CDMO Services Market Size Growth (2020-2025)
4.4 APAC Viral Vector CDMO Services Market Size Growth (2020-2025)
4.5 Europe Viral Vector CDMO Services Market Size Growth (2020-2025)
4.6 Middle East & Africa Viral Vector CDMO Services Market Size Growth (2020-2025)
5 Americas
5.1 Americas Viral Vector CDMO Services Market Size by Country (2020-2025)
5.2 Americas Viral Vector CDMO Services Market Size by Type (2020-2025)
5.3 Americas Viral Vector CDMO Services Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Viral Vector CDMO Services Market Size by Region (2020-2025)
6.2 APAC Viral Vector CDMO Services Market Size by Type (2020-2025)
6.3 APAC Viral Vector CDMO Services Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Viral Vector CDMO Services Market Size by Country (2020-2025)
7.2 Europe Viral Vector CDMO Services Market Size by Type (2020-2025)
7.3 Europe Viral Vector CDMO Services Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Viral Vector CDMO Services by Region (2020-2025)
8.2 Middle East & Africa Viral Vector CDMO Services Market Size by Type (2020-2025)
8.3 Middle East & Africa Viral Vector CDMO Services Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Viral Vector CDMO Services Market Forecast
10.1 Global Viral Vector CDMO Services Forecast by Region (2026-2031)
10.1.1 Global Viral Vector CDMO Services Forecast by Region (2026-2031)
10.1.2 Americas Viral Vector CDMO Services Forecast
10.1.3 APAC Viral Vector CDMO Services Forecast
10.1.4 Europe Viral Vector CDMO Services Forecast
10.1.5 Middle East & Africa Viral Vector CDMO Services Forecast
10.2 Americas Viral Vector CDMO Services Forecast by Country (2026-2031)
10.2.1 United States Market Viral Vector CDMO Services Forecast
10.2.2 Canada Market Viral Vector CDMO Services Forecast
10.2.3 Mexico Market Viral Vector CDMO Services Forecast
10.2.4 Brazil Market Viral Vector CDMO Services Forecast
10.3 APAC Viral Vector CDMO Services Forecast by Region (2026-2031)
10.3.1 China Viral Vector CDMO Services Market Forecast
10.3.2 Japan Market Viral Vector CDMO Services Forecast
10.3.3 Korea Market Viral Vector CDMO Services Forecast
10.3.4 Southeast Asia Market Viral Vector CDMO Services Forecast
10.3.5 India Market Viral Vector CDMO Services Forecast
10.3.6 Australia Market Viral Vector CDMO Services Forecast
10.4 Europe Viral Vector CDMO Services Forecast by Country (2026-2031)
10.4.1 Germany Market Viral Vector CDMO Services Forecast
10.4.2 France Market Viral Vector CDMO Services Forecast
10.4.3 UK Market Viral Vector CDMO Services Forecast
10.4.4 Italy Market Viral Vector CDMO Services Forecast
10.4.5 Russia Market Viral Vector CDMO Services Forecast
10.5 Middle East & Africa Viral Vector CDMO Services Forecast by Region (2026-2031)
10.5.1 Egypt Market Viral Vector CDMO Services Forecast
10.5.2 South Africa Market Viral Vector CDMO Services Forecast
10.5.3 Israel Market Viral Vector CDMO Services Forecast
10.5.4 Turkey Market Viral Vector CDMO Services Forecast
10.6 Global Viral Vector CDMO Services Forecast by Type (2026-2031)
10.7 Global Viral Vector CDMO Services Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Viral Vector CDMO Services Forecast
11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Viral Vector CDMO Services Product Offered
11.1.3 Thermo Fisher Scientific Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Lonza
11.2.1 Lonza Company Information
11.2.2 Lonza Viral Vector CDMO Services Product Offered
11.2.3 Lonza Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Lonza Main Business Overview
11.2.5 Lonza Latest Developments
11.3 Catalent
11.3.1 Catalent Company Information
11.3.2 Catalent Viral Vector CDMO Services Product Offered
11.3.3 Catalent Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Catalent Main Business Overview
11.3.5 Catalent Latest Developments
11.4 Charles River
11.4.1 Charles River Company Information
11.4.2 Charles River Viral Vector CDMO Services Product Offered
11.4.3 Charles River Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Charles River Main Business Overview
11.4.5 Charles River Latest Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck Viral Vector CDMO Services Product Offered
11.5.3 Merck Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Merck Main Business Overview
11.5.5 Merck Latest Developments
11.6 SK pharmteco
11.6.1 SK pharmteco Company Information
11.6.2 SK pharmteco Viral Vector CDMO Services Product Offered
11.6.3 SK pharmteco Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 SK pharmteco Main Business Overview
11.6.5 SK pharmteco Latest Developments
11.7 Oxford Biomedica
11.7.1 Oxford Biomedica Company Information
11.7.2 Oxford Biomedica Viral Vector CDMO Services Product Offered
11.7.3 Oxford Biomedica Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Oxford Biomedica Main Business Overview
11.7.5 Oxford Biomedica Latest Developments
11.8 AGC Biologics（MolMed）
11.8.1 AGC Biologics（MolMed） Company Information
11.8.2 AGC Biologics（MolMed） Viral Vector CDMO Services Product Offered
11.8.3 AGC Biologics（MolMed） Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 AGC Biologics（MolMed） Main Business Overview
11.8.5 AGC Biologics（MolMed） Latest Developments
11.9 Gene Universal
11.9.1 Gene Universal Company Information
11.9.2 Gene Universal Viral Vector CDMO Services Product Offered
11.9.3 Gene Universal Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Gene Universal Main Business Overview
11.9.5 Gene Universal Latest Developments
11.10 Polyplus (Sartorius)
11.10.1 Polyplus (Sartorius) Company Information
11.10.2 Polyplus (Sartorius) Viral Vector CDMO Services Product Offered
11.10.3 Polyplus (Sartorius) Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Polyplus (Sartorius) Main Business Overview
11.10.5 Polyplus (Sartorius) Latest Developments
11.11 CCRM
11.11.1 CCRM Company Information
11.11.2 CCRM Viral Vector CDMO Services Product Offered
11.11.3 CCRM Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 CCRM Main Business Overview
11.11.5 CCRM Latest Developments
11.12 FUJIFILM Diosynth Biotechnologies
11.12.1 FUJIFILM Diosynth Biotechnologies Company Information
11.12.2 FUJIFILM Diosynth Biotechnologies Viral Vector CDMO Services Product Offered
11.12.3 FUJIFILM Diosynth Biotechnologies Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.12.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.13 Biovian
11.13.1 Biovian Company Information
11.13.2 Biovian Viral Vector CDMO Services Product Offered
11.13.3 Biovian Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Biovian Main Business Overview
11.13.5 Biovian Latest Developments
11.14 Miltenyi Bioindustry
11.14.1 Miltenyi Bioindustry Company Information
11.14.2 Miltenyi Bioindustry Viral Vector CDMO Services Product Offered
11.14.3 Miltenyi Bioindustry Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Miltenyi Bioindustry Main Business Overview
11.14.5 Miltenyi Bioindustry Latest Developments
11.15 Aldevron
11.15.1 Aldevron Company Information
11.15.2 Aldevron Viral Vector CDMO Services Product Offered
11.15.3 Aldevron Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Aldevron Main Business Overview
11.15.5 Aldevron Latest Developments
11.16 Takara Bio
11.16.1 Takara Bio Company Information
11.16.2 Takara Bio Viral Vector CDMO Services Product Offered
11.16.3 Takara Bio Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Takara Bio Main Business Overview
11.16.5 Takara Bio Latest Developments
11.17 Yposkesi
11.17.1 Yposkesi Company Information
11.17.2 Yposkesi Viral Vector CDMO Services Product Offered
11.17.3 Yposkesi Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Yposkesi Main Business Overview
11.17.5 Yposkesi Latest Developments
11.18 Genezen
11.18.1 Genezen Company Information
11.18.2 Genezen Viral Vector CDMO Services Product Offered
11.18.3 Genezen Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Genezen Main Business Overview
11.18.5 Genezen Latest Developments
11.19 GenScript ProBio
11.19.1 GenScript ProBio Company Information
11.19.2 GenScript ProBio Viral Vector CDMO Services Product Offered
11.19.3 GenScript ProBio Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 GenScript ProBio Main Business Overview
11.19.5 GenScript ProBio Latest Developments
11.20 EurekaBio
11.20.1 EurekaBio Company Information
11.20.2 EurekaBio Viral Vector CDMO Services Product Offered
11.20.3 EurekaBio Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 EurekaBio Main Business Overview
11.20.5 EurekaBio Latest Developments
11.21 Obio Technology
11.21.1 Obio Technology Company Information
11.21.2 Obio Technology Viral Vector CDMO Services Product Offered
11.21.3 Obio Technology Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Obio Technology Main Business Overview
11.21.5 Obio Technology Latest Developments
11.22 GeneSail Biotech
11.22.1 GeneSail Biotech Company Information
11.22.2 GeneSail Biotech Viral Vector CDMO Services Product Offered
11.22.3 GeneSail Biotech Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 GeneSail Biotech Main Business Overview
11.22.5 GeneSail Biotech Latest Developments
11.23 VectorBuilder
11.23.1 VectorBuilder Company Information
11.23.2 VectorBuilder Viral Vector CDMO Services Product Offered
11.23.3 VectorBuilder Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.23.4 VectorBuilder Main Business Overview
11.23.5 VectorBuilder Latest Developments
11.24 WuXi ATU
11.24.1 WuXi ATU Company Information
11.24.2 WuXi ATU Viral Vector CDMO Services Product Offered
11.24.3 WuXi ATU Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.24.4 WuXi ATU Main Business Overview
11.24.5 WuXi ATU Latest Developments
11.25 Ubrigene
11.25.1 Ubrigene Company Information
11.25.2 Ubrigene Viral Vector CDMO Services Product Offered
11.25.3 Ubrigene Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.25.4 Ubrigene Main Business Overview
11.25.5 Ubrigene Latest Developments
11.26 Porton Biologics
11.26.1 Porton Biologics Company Information
11.26.2 Porton Biologics Viral Vector CDMO Services Product Offered
11.26.3 Porton Biologics Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.26.4 Porton Biologics Main Business Overview
11.26.5 Porton Biologics Latest Developments
11.27 Pharmaron
11.27.1 Pharmaron Company Information
11.27.2 Pharmaron Viral Vector CDMO Services Product Offered
11.27.3 Pharmaron Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.27.4 Pharmaron Main Business Overview
11.27.5 Pharmaron Latest Developments
11.28 PackGene Biotechnology
11.28.1 PackGene Biotechnology Company Information
11.28.2 PackGene Biotechnology Viral Vector CDMO Services Product Offered
11.28.3 PackGene Biotechnology Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.28.4 PackGene Biotechnology Main Business Overview
11.28.5 PackGene Biotechnology Latest Developments
11.29 Hillgene
11.29.1 Hillgene Company Information
11.29.2 Hillgene Viral Vector CDMO Services Product Offered
11.29.3 Hillgene Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.29.4 Hillgene Main Business Overview
11.29.5 Hillgene Latest Developments
11.30 Asymchem
11.30.1 Asymchem Company Information
11.30.2 Asymchem Viral Vector CDMO Services Product Offered
11.30.3 Asymchem Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.30.4 Asymchem Main Business Overview
11.30.5 Asymchem Latest Developments
11.31 Exthera
11.31.1 Exthera Company Information
11.31.2 Exthera Viral Vector CDMO Services Product Offered
11.31.3 Exthera Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.31.4 Exthera Main Business Overview
11.31.5 Exthera Latest Developments
11.32 Flash Therapeutics
11.32.1 Flash Therapeutics Company Information
11.32.2 Flash Therapeutics Viral Vector CDMO Services Product Offered
11.32.3 Flash Therapeutics Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.32.4 Flash Therapeutics Main Business Overview
11.32.5 Flash Therapeutics Latest Developments
11.33 VIVEBiotech
11.33.1 VIVEBiotech Company Information
11.33.2 VIVEBiotech Viral Vector CDMO Services Product Offered
11.33.3 VIVEBiotech Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.33.4 VIVEBiotech Main Business Overview
11.33.5 VIVEBiotech Latest Developments
11.34 FinVector
11.34.1 FinVector Company Information
11.34.2 FinVector Viral Vector CDMO Services Product Offered
11.34.3 FinVector Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.34.4 FinVector Main Business Overview
11.34.5 FinVector Latest Developments
11.35 uBriGene
11.35.1 uBriGene Company Information
11.35.2 uBriGene Viral Vector CDMO Services Product Offered
11.35.3 uBriGene Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.35.4 uBriGene Main Business Overview
11.35.5 uBriGene Latest Developments
11.36 Eurogentec
11.36.1 Eurogentec Company Information
11.36.2 Eurogentec Viral Vector CDMO Services Product Offered
11.36.3 Eurogentec Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.36.4 Eurogentec Main Business Overview
11.36.5 Eurogentec Latest Developments
11.37 VGXI
11.37.1 VGXI Company Information
11.37.2 VGXI Viral Vector CDMO Services Product Offered
11.37.3 VGXI Viral Vector CDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.37.4 VGXI Main Business Overview
11.37.5 VGXI Latest Developments
12 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Viral Vector CDMO Services Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Viral Vector CDMO Services Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of AAV
Table 4. Major Players of Lentivirus
Table 5. Major Players of Adenovirus
Table 6. Major Players of HSV
Table 7. Major Players of Others
Table 8. Viral Vector CDMO Services Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Viral Vector CDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Viral Vector CDMO Services Market Size Market Share by Type (2020-2025)
Table 11. Viral Vector CDMO Services Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Viral Vector CDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Viral Vector CDMO Services Market Size Market Share by Application (2020-2025)
Table 14. Global Viral Vector CDMO Services Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Viral Vector CDMO Services Revenue Market Share by Player (2020-2025)
Table 16. Viral Vector CDMO Services Key Players Head office and Products Offered
Table 17. Viral Vector CDMO Services Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Viral Vector CDMO Services Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Viral Vector CDMO Services Market Size Market Share by Region (2020-2025)
Table 22. Global Viral Vector CDMO Services Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Viral Vector CDMO Services Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Viral Vector CDMO Services Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Viral Vector CDMO Services Market Size Market Share by Country (2020-2025)
Table 26. Americas Viral Vector CDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Viral Vector CDMO Services Market Size Market Share by Type (2020-2025)
Table 28. Americas Viral Vector CDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Viral Vector CDMO Services Market Size Market Share by Application (2020-2025)
Table 30. APAC Viral Vector CDMO Services Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Viral Vector CDMO Services Market Size Market Share by Region (2020-2025)
Table 32. APAC Viral Vector CDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Viral Vector CDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Viral Vector CDMO Services Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Viral Vector CDMO Services Market Size Market Share by Country (2020-2025)
Table 36. Europe Viral Vector CDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Viral Vector CDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Viral Vector CDMO Services Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Viral Vector CDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Viral Vector CDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Viral Vector CDMO Services
Table 42. Key Market Challenges & Risks of Viral Vector CDMO Services
Table 43. Key Industry Trends of Viral Vector CDMO Services
Table 44. Global Viral Vector CDMO Services Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Viral Vector CDMO Services Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Viral Vector CDMO Services Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Viral Vector CDMO Services Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. Thermo Fisher Scientific Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 49. Thermo Fisher Scientific Viral Vector CDMO Services Product Offered
Table 50. Thermo Fisher Scientific Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Thermo Fisher Scientific Main Business
Table 52. Thermo Fisher Scientific Latest Developments
Table 53. Lonza Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 54. Lonza Viral Vector CDMO Services Product Offered
Table 55. Lonza Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Lonza Main Business
Table 57. Lonza Latest Developments
Table 58. Catalent Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 59. Catalent Viral Vector CDMO Services Product Offered
Table 60. Catalent Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Catalent Main Business
Table 62. Catalent Latest Developments
Table 63. Charles River Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 64. Charles River Viral Vector CDMO Services Product Offered
Table 65. Charles River Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Charles River Main Business
Table 67. Charles River Latest Developments
Table 68. Merck Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 69. Merck Viral Vector CDMO Services Product Offered
Table 70. Merck Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Merck Main Business
Table 72. Merck Latest Developments
Table 73. SK pharmteco Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 74. SK pharmteco Viral Vector CDMO Services Product Offered
Table 75. SK pharmteco Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. SK pharmteco Main Business
Table 77. SK pharmteco Latest Developments
Table 78. Oxford Biomedica Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 79. Oxford Biomedica Viral Vector CDMO Services Product Offered
Table 80. Oxford Biomedica Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Oxford Biomedica Main Business
Table 82. Oxford Biomedica Latest Developments
Table 83. AGC Biologics（MolMed） Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 84. AGC Biologics（MolMed） Viral Vector CDMO Services Product Offered
Table 85. AGC Biologics（MolMed） Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. AGC Biologics（MolMed） Main Business
Table 87. AGC Biologics（MolMed） Latest Developments
Table 88. Gene Universal Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 89. Gene Universal Viral Vector CDMO Services Product Offered
Table 90. Gene Universal Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Gene Universal Main Business
Table 92. Gene Universal Latest Developments
Table 93. Polyplus (Sartorius) Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 94. Polyplus (Sartorius) Viral Vector CDMO Services Product Offered
Table 95. Polyplus (Sartorius) Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Polyplus (Sartorius) Main Business
Table 97. Polyplus (Sartorius) Latest Developments
Table 98. CCRM Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 99. CCRM Viral Vector CDMO Services Product Offered
Table 100. CCRM Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 101. CCRM Main Business
Table 102. CCRM Latest Developments
Table 103. FUJIFILM Diosynth Biotechnologies Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 104. FUJIFILM Diosynth Biotechnologies Viral Vector CDMO Services Product Offered
Table 105. FUJIFILM Diosynth Biotechnologies Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 106. FUJIFILM Diosynth Biotechnologies Main Business
Table 107. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 108. Biovian Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 109. Biovian Viral Vector CDMO Services Product Offered
Table 110. Biovian Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 111. Biovian Main Business
Table 112. Biovian Latest Developments
Table 113. Miltenyi Bioindustry Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 114. Miltenyi Bioindustry Viral Vector CDMO Services Product Offered
Table 115. Miltenyi Bioindustry Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 116. Miltenyi Bioindustry Main Business
Table 117. Miltenyi Bioindustry Latest Developments
Table 118. Aldevron Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 119. Aldevron Viral Vector CDMO Services Product Offered
Table 120. Aldevron Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 121. Aldevron Main Business
Table 122. Aldevron Latest Developments
Table 123. Takara Bio Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 124. Takara Bio Viral Vector CDMO Services Product Offered
Table 125. Takara Bio Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 126. Takara Bio Main Business
Table 127. Takara Bio Latest Developments
Table 128. Yposkesi Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 129. Yposkesi Viral Vector CDMO Services Product Offered
Table 130. Yposkesi Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 131. Yposkesi Main Business
Table 132. Yposkesi Latest Developments
Table 133. Genezen Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 134. Genezen Viral Vector CDMO Services Product Offered
Table 135. Genezen Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 136. Genezen Main Business
Table 137. Genezen Latest Developments
Table 138. GenScript ProBio Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 139. GenScript ProBio Viral Vector CDMO Services Product Offered
Table 140. GenScript ProBio Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 141. GenScript ProBio Main Business
Table 142. GenScript ProBio Latest Developments
Table 143. EurekaBio Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 144. EurekaBio Viral Vector CDMO Services Product Offered
Table 145. EurekaBio Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 146. EurekaBio Main Business
Table 147. EurekaBio Latest Developments
Table 148. Obio Technology Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 149. Obio Technology Viral Vector CDMO Services Product Offered
Table 150. Obio Technology Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 151. Obio Technology Main Business
Table 152. Obio Technology Latest Developments
Table 153. GeneSail Biotech Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 154. GeneSail Biotech Viral Vector CDMO Services Product Offered
Table 155. GeneSail Biotech Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 156. GeneSail Biotech Main Business
Table 157. GeneSail Biotech Latest Developments
Table 158. VectorBuilder Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 159. VectorBuilder Viral Vector CDMO Services Product Offered
Table 160. VectorBuilder Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 161. VectorBuilder Main Business
Table 162. VectorBuilder Latest Developments
Table 163. WuXi ATU Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 164. WuXi ATU Viral Vector CDMO Services Product Offered
Table 165. WuXi ATU Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 166. WuXi ATU Main Business
Table 167. WuXi ATU Latest Developments
Table 168. Ubrigene Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 169. Ubrigene Viral Vector CDMO Services Product Offered
Table 170. Ubrigene Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 171. Ubrigene Main Business
Table 172. Ubrigene Latest Developments
Table 173. Porton Biologics Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 174. Porton Biologics Viral Vector CDMO Services Product Offered
Table 175. Porton Biologics Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 176. Porton Biologics Main Business
Table 177. Porton Biologics Latest Developments
Table 178. Pharmaron Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 179. Pharmaron Viral Vector CDMO Services Product Offered
Table 180. Pharmaron Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 181. Pharmaron Main Business
Table 182. Pharmaron Latest Developments
Table 183. PackGene Biotechnology Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 184. PackGene Biotechnology Viral Vector CDMO Services Product Offered
Table 185. PackGene Biotechnology Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 186. PackGene Biotechnology Main Business
Table 187. PackGene Biotechnology Latest Developments
Table 188. Hillgene Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 189. Hillgene Viral Vector CDMO Services Product Offered
Table 190. Hillgene Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 191. Hillgene Main Business
Table 192. Hillgene Latest Developments
Table 193. Asymchem Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 194. Asymchem Viral Vector CDMO Services Product Offered
Table 195. Asymchem Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 196. Asymchem Main Business
Table 197. Asymchem Latest Developments
Table 198. Exthera Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 199. Exthera Viral Vector CDMO Services Product Offered
Table 200. Exthera Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 201. Exthera Main Business
Table 202. Exthera Latest Developments
Table 203. Flash Therapeutics Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 204. Flash Therapeutics Viral Vector CDMO Services Product Offered
Table 205. Flash Therapeutics Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 206. Flash Therapeutics Main Business
Table 207. Flash Therapeutics Latest Developments
Table 208. VIVEBiotech Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 209. VIVEBiotech Viral Vector CDMO Services Product Offered
Table 210. VIVEBiotech Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 211. VIVEBiotech Main Business
Table 212. VIVEBiotech Latest Developments
Table 213. FinVector Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 214. FinVector Viral Vector CDMO Services Product Offered
Table 215. FinVector Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 216. FinVector Main Business
Table 217. FinVector Latest Developments
Table 218. uBriGene Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 219. uBriGene Viral Vector CDMO Services Product Offered
Table 220. uBriGene Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 221. uBriGene Main Business
Table 222. uBriGene Latest Developments
Table 223. Eurogentec Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 224. Eurogentec Viral Vector CDMO Services Product Offered
Table 225. Eurogentec Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 226. Eurogentec Main Business
Table 227. Eurogentec Latest Developments
Table 228. VGXI Details, Company Type, Viral Vector CDMO Services Area Served and Its Competitors
Table 229. VGXI Viral Vector CDMO Services Product Offered
Table 230. VGXI Viral Vector CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 231. VGXI Main Business
Table 232. VGXI Latest Developments


List of Figures
Figure 1. Viral Vector CDMO Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Viral Vector CDMO Services Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Viral Vector CDMO Services Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Viral Vector CDMO Services Sales Market Share by Country/Region (2024)
Figure 8. Viral Vector CDMO Services Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Viral Vector CDMO Services Market Size Market Share by Type in 2024
Figure 10. Viral Vector CDMO Services in Vaccine Development
Figure 11. Global Viral Vector CDMO Services Market: Vaccine Development (2020-2025) & ($ millions)
Figure 12. Viral Vector CDMO Services in Gene Therapy
Figure 13. Global Viral Vector CDMO Services Market: Gene Therapy (2020-2025) & ($ millions)
Figure 14. Viral Vector CDMO Services in Academic Scientific Research Institution
Figure 15. Global Viral Vector CDMO Services Market: Academic Scientific Research Institution (2020-2025) & ($ millions)
Figure 16. Viral Vector CDMO Services in Others
Figure 17. Global Viral Vector CDMO Services Market: Others (2020-2025) & ($ millions)
Figure 18. Global Viral Vector CDMO Services Market Size Market Share by Application in 2024
Figure 19. Global Viral Vector CDMO Services Revenue Market Share by Player in 2024
Figure 20. Global Viral Vector CDMO Services Market Size Market Share by Region (2020-2025)
Figure 21. Americas Viral Vector CDMO Services Market Size 2020-2025 ($ millions)
Figure 22. APAC Viral Vector CDMO Services Market Size 2020-2025 ($ millions)
Figure 23. Europe Viral Vector CDMO Services Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Viral Vector CDMO Services Market Size 2020-2025 ($ millions)
Figure 25. Americas Viral Vector CDMO Services Value Market Share by Country in 2024
Figure 26. United States Viral Vector CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Viral Vector CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Viral Vector CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Viral Vector CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Viral Vector CDMO Services Market Size Market Share by Region in 2024
Figure 31. APAC Viral Vector CDMO Services Market Size Market Share by Type (2020-2025)
Figure 32. APAC Viral Vector CDMO Services Market Size Market Share by Application (2020-2025)
Figure 33. China Viral Vector CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Viral Vector CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Viral Vector CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Viral Vector CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 37. India Viral Vector CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Viral Vector CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Viral Vector CDMO Services Market Size Market Share by Country in 2024
Figure 40. Europe Viral Vector CDMO Services Market Size Market Share by Type (2020-2025)
Figure 41. Europe Viral Vector CDMO Services Market Size Market Share by Application (2020-2025)
Figure 42. Germany Viral Vector CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 43. France Viral Vector CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Viral Vector CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Viral Vector CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Viral Vector CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Viral Vector CDMO Services Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Viral Vector CDMO Services Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Viral Vector CDMO Services Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Viral Vector CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Viral Vector CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Viral Vector CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Viral Vector CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Viral Vector CDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Viral Vector CDMO Services Market Size 2026-2031 ($ millions)
Figure 56. APAC Viral Vector CDMO Services Market Size 2026-2031 ($ millions)
Figure 57. Europe Viral Vector CDMO Services Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Viral Vector CDMO Services Market Size 2026-2031 ($ millions)
Figure 59. United States Viral Vector CDMO Services Market Size 2026-2031 ($ millions)
Figure 60. Canada Viral Vector CDMO Services Market Size 2026-2031 ($ millions)
Figure 61. Mexico Viral Vector CDMO Services Market Size 2026-2031 ($ millions)
Figure 62. Brazil Viral Vector CDMO Services Market Size 2026-2031 ($ millions)
Figure 63. China Viral Vector CDMO Services Market Size 2026-2031 ($ millions)
Figure 64. Japan Viral Vector CDMO Services Market Size 2026-2031 ($ millions)
Figure 65. Korea Viral Vector CDMO Services Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Viral Vector CDMO Services Market Size 2026-2031 ($ millions)
Figure 67. India Viral Vector CDMO Services Market Size 2026-2031 ($ millions)
Figure 68. Australia Viral Vector CDMO Services Market Size 2026-2031 ($ millions)
Figure 69. Germany Viral Vector CDMO Services Market Size 2026-2031 ($ millions)
Figure 70. France Viral Vector CDMO Services Market Size 2026-2031 ($ millions)
Figure 71. UK Viral Vector CDMO Services Market Size 2026-2031 ($ millions)
Figure 72. Italy Viral Vector CDMO Services Market Size 2026-2031 ($ millions)
Figure 73. Russia Viral Vector CDMO Services Market Size 2026-2031 ($ millions)
Figure 74. Egypt Viral Vector CDMO Services Market Size 2026-2031 ($ millions)
Figure 75. South Africa Viral Vector CDMO Services Market Size 2026-2031 ($ millions)
Figure 76. Israel Viral Vector CDMO Services Market Size 2026-2031 ($ millions)
Figure 77. Turkey Viral Vector CDMO Services Market Size 2026-2031 ($ millions)
Figure 78. Global Viral Vector CDMO Services Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Viral Vector CDMO Services Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Viral Vector CDMO Services Market Size 2026-2031 ($ millions)